The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Looks like a sell to me based on the published trades and cancelled trades, but who really knows. Hopefully it's a buy!
I would like to average down after buying at 2p but I'm not convinced we're on the road to recovery yet.
Incredible half-year results for AVAP, with the highlight for me being NAV up from £2.68 to £2.82
Swung from a -£15.9m loss to a £6.7mil profit before tax.
Net indebtedness reduced by nearly 6%
"The airline industry is continuing its recovery from the lows seen during the COVID-19 pandemic. Global domestic air travel in December 2022 as reported by IATA, has recovered to around 79.9% of December 2019 passenger numbers while international travel, while lagging, has recovered to around 75.1% of December 2019 levels. "
Still plenty of recovery to come in airline traffic, especially in Asia where China's zero-covid policies have restricted recovery until very recently.
"The Company believes that airlines will require significant numbers of leased aircraft in the short to medium term due to the large number of older aircraft that have been retired as a result of the COVID-19 pandemic, and the impact of the pandemic on airline balance sheets, reducing their ability to purchase aircraft directly."
Speaks for itself.
No exposure to Russian airlines!
"We note that most of our peer leasing companies have suffered large losses due to the seizure of aircraft leased to Russian airlines. Avation was fortunate in that it did not have any exposure to Russian airlines. Our policy is, and has always been, to only lease planes in jurisdictions where we are confident that we can arrange repossession, if ever required."
This should be +20% already today and trading at £1.60+, but it's taking time for the market to realise the recovery in AVAPs intrinsic value, which is great as it has allowed me to load up even more this morning.
Time to sit back and relax now and watch the market gradually wake up over the coming days and weeks.
All IMO so DYOR!
Maybe a lot later than expected, but IO#9 has finally been confirmed and it looks like IO#10 might not be too far away.
https://www.investegate.co.uk/iofina-plc--iof-/rns/finalised-terms-for-io9---q3-production-update/202210280700054131E/
"Iofina anticipates expanding iodine production in this region to create a new core area for the Company and is actively developing plans for a second plant in this area."
Easily worth 30p+ in the short-term IMO and more like 40p+ when IO#10 gets confirmed.
Pier has performed very well in recovering from lockdowns etc and management should be applauded for that.
The current market rejection is more about forward-looking statements IMO, with the broker figures being quoted by the FD on the last presentation not giving much hope to current or prospective new investors. A reduction in profit for FY23 was always going to be a tough pill to swallow, compounded by the extremely cautious outlook statement in the most recent results.
For me it's a great looking company but with the pressure on operating costs and margin expected over the next year or two, I would want the value to be lower in order to invest and expect a return.
The board have also stated that a dividend is a possibility in future but they would prefer to make acquisitions to grow the group. This could prove to be a great move over the medium to long-term but the market doesn't like the uncertainty right now.
I'll be keeping an eye on PIER and might have a nibble if it continues to drop but for now I'm watching from the sidelines.
Buy-backs
No guarantee that they will buy back any shares, but nice to know the option is there. I personally believe this SP is really undervalued at <30p so would like to see the company hoovering up at current prices.
There is a school of thought that the buy-back started almost immediately following approval at the AGM on Wednesday, as there have been several large, round trades going through since then at mid-price, so not showing as a buy or a sell. Most companies report buy-backs the following day regardless of volume, rather than when exceeding specific levels, so I think it's unlikely they've started buying yet.
More likely Richard Sneller still working his way towards 20%, or another II or HNWI building a stake under the radar.
Either way, there is so much to be positive about with IOF right now, I'm quite comfy having them make up a big chunk of my ISA.
All IMO so DYOR ;)
Does seem to be fairly consistent values being bought per day, except on 7th June. Any idea why or how they were able to push through £1.8mil on that day?
https://www.lse.co.uk/rns/TRMR/transaction-in-own-shares-lb5jy28cv1m2rqh.html
".....announces that on 7 June 2022 it bought-back 365,800 ordinary shares of NIS0.01 each in the capital of the Company ("Ordinary Shares") in the AIM market at an average price of 489.9 pence per Ordinary Share."
Either way, this is fast becoming the most undervalued share on AIM and I'm adding at these bargain prices!
Another great development for IMMO, and a foot in the door of the very lucrative licensing opportunity in China.
"Leke VR has an aggressive roll-out plan in this sector and to be doing this under a licensing agreement using our 'Undersea Explorer' brand allows us to further monetise our oceanographic VR experiences without having the burden of capital outlay or operational challenges."
Yes I saw that, but I find the 50% by June target a little hard to fathom, especially when you consider the missed deadlines thus far on the Cashew project.
A little more transparency on the market price and average prices achieved would be very welcome and would potentially give investors some additional belief/hope.
However, I do know that the majority of the world's cashews are grown in West Africa, then shipped to India for processing before being shipped back to Europe, North America etc.
So if Dekel manage to reach 95%+ processing capacity and they are able to avoid major losses from inefficiencies, poor harvests, corruption and other key risk factors, they should have a very profitable Cashew processing plant on their hands to complement their sustainable Palm Oil operation.
Anyone got a decent view of competitors in similar region with similar operations?
Hi everyone, sorry in advance for any ignorant comments, I'm relatively new to Dekel and still doing my due diligence.
I'm trying to understand what could be the catalyst for a change in the direction of the SP, and had my eye on the high season finally arriving. That now appears to be drifting away without so much as a drop of rain in the Eastern parts of the country (which of course is outside of DKLs control) so the attention naturally turns to the ramping up of the Cashew processing facility, which was what initially attracted me to Dekel.
There does seem to be a few key figures missing in terms of the current and potential financial performance of the Cashew processing facility. I understand that they're currently at c.15% of capacity, and new parts are either on the way, or due to be on their way in the coming weeks from China, Italy etc. This feels to me like they will not get close to 95%+ of capacity for at least a few months as shipping, clearing, transporting, commissioning etc could all be subject to further delays.
So I'm left wondering what will cause the SP to stop dropping? I do really like the company from what I've seen so far and have a personal interest in Cashew processing, but AIM is littered with "good" companies that lose their investors money, so I'm not in any great rush to dive in. Particularly with the wider market sentiment currently at such a low point, and the old adage of "Sell in May and go away....."
Does anyone here have any educated views on the financial potential of the Cashew plant? And any inklings on news in the coming days/weeks/months that might just steady the ship or even get the SP appreciating again?
Thanks in advance,
Faz
For balance, here is the very cautious and almost negative Outlook statement:
With a strong order book, the Directors believe at this time that the second half trading will be in line with the first half trading subject to further disruptions by COVID-19 and/or supply chain and logistics challenges. The Directors caution that the risks in the supply chain are substantial and there will very likely be disruptions impacting the business.
For balance, here is the very cautious and almost negative Outlook statement:
With a strong order book, the Directors believe at this time that the second half trading will be in line with the first half trading subject to further disruptions by COVID-19 and/or supply chain and logistics challenges. The Directors caution that the risks in the supply chain are substantial and there will very likely be disruptions impacting the business.
Tim Losik, President & CEO, commented:
Financial
"Overall, I am pleased with our results for the first half of 2021. The Company experienced improvement in virtually every financial metric, including revenue, gross profit, operating income, net income and adjusted EBITDA as compared to the first half of 2020. Further, we increased our cash balance to $3.0 million, while further paying down debt.
Been following WATR for a while and kept regretting not getting in earlier, but today's contract news was too enticing to ignore, especially after the retrace from 1000p+ recently. WATR looks like a great short, medium and long-term hold based on the fundamentals and the exponential growth they have achieved despite the pandemic, and the chart is looking very positive with clear bullish divergence on the RSI on the daily.
Look forward to more contracts and continued strong growth.
On the basis of Iofina's growth trajectory and debt refinancing alone, they should be worth £50-£60mil in my opinion, or 26-31p.
When you factor in the plans for expansion, the growing demand for Iodine and derivative products and the associated increasing price of Iodine, a valuation of £100mil+ or 52p could easily be justified.
Remember, the company is now in a stronger position than it has ever been before!
DYOR though ;)
Great news for Clipper, a company I've been watching for a while. Finally took a position this morning after seeing this update!
"Together, these two new contracts will increase revenue by over £40 million on a full-year basis, and will be immediately earnings-enhancing from go-live. As a result, the Group expects to outperform current market expectations in the year to 30 April 2022 and beyond."
SEEuJIMMY - whoever the big buyer is, who has been buying over the last month or 2 has almost certainly bought more than 37mil shares or 1% of the company, so if it was an existing holder they would have had to declare by now. It is possible that there is more than one big buyer hoovering up any sells - afterall Paul McG did promise "additional on-market interest" following the strategic investment by Federated. I'm still expecting Kaufmann fund to take a position, and for Lombard to get their holding back to 19.99%, and then there is the possiblity of Kabouter etc. who SEE presented to at the same time as Fed Herm.
I'm not really worried about a low-ball bid though, I think we have got the protection we need from significant shareholders now.
All IMO, DYOR etc.